The Role of NLRP3 and IL-1β in Refractory Epilepsy Brain Injury

Objective: The objective of this study was to investigate the roles and mechanisms of inflammatory mediators NLRP3 and IL-1β in refractory temporal epilepsy brain injury. Method: First, the brain tissue and the peripheral blood of children undergoing intractable temporal lobe epilepsy surgery were analyzed as research objects. The expression levels of NLRP3 in brain tissue and IL-1β in blood were measured. A model of temporal lobe epilepsy was established using wild-type and NLRP3 knockout 129 mice. Pilocarpine was injected intraperitoneally into the experimental group, and isovolumetric saline was injected intraperitoneally into the control group (n = 8 in each group). The expression of IL-1β in the peripheral blood, cerebral cortex, and hippocampus of mice was measured by ELISA at 3 h, 24 h, 3 days, and 7 days after modeling. Fluoro-Jade B (FJB) and TUNEL methods were used to determine necrosis and apoptosis in hippocampal neurons, respectively, and the expression of NLRP3 in the cortex was measured by immunofluorescence methods. Result: (1) The IL-1β levels in the peripheral blood of children with intractable temporal lobe epilepsy were higher than those in the control group (t = 2.813, P = 0.01). There was also a positive correlation between IL-1β expression levels and the onset time of a single convulsion in patients with refractory epilepsy (r = 0.9735, P < 0.05). The expression level of NLRP3 in the cerebral cortex of patients with refractory temporal lobe epilepsy was higher than that in the control group. (2) The expression level of NLRP3 in the hippocampus of wild-type mice increased 3 days after modeling and decreased slightly at 7 days but remained higher than that of the control group. IL-1β levels in peripheral blood were significantly higher than those in the control group at 3 days (t = 8.259, P < 0.0001). The IL-1β levels in the peripheral blood of NLRP3 knockout mice were lower than those in the wild-type group at 3 days (t = 3.481, P = 0.004). At day 7, the neuronal necrosis and apoptosis levels in the CA3 region of the hippocampus decreased. Conclusion: NLRP3 may be involved in the development of refractory temporal lobe epilepsy. Inhibiting NLRP3 may alleviate local brain injury by downregulating the IL-1β expression. The IL-1β levels in the peripheral blood of patients with refractory temporal lobe epilepsy may reflect the severity of convulsions.

[1]  Xiaoling Li,et al.  FK506 Attenuated Pilocarpine-Induced Epilepsy by Reducing Inflammation in Rats , 2019, Front. Neurol..

[2]  P. Iwanowski,et al.  Advances in the Potential Biomarkers of Epilepsy , 2019, Front. Neurol..

[3]  Qianchao He,et al.  Curcumin Reduces Neuronal Loss and Inhibits the NLRP3 Inflammasome Activation in an Epileptic Rat Model , 2018, Current neurovascular research.

[4]  Zhanjun Jia,et al.  Angiotensin II Stimulates the NLRP3 Inflammasome to Induce Podocyte Injury and Mitochondrial Dysfunction , 2018, Kidney Diseases.

[5]  S. Orozco-Suárez,et al.  Follow-Up of Peripheral IL-1β and IL-6 and Relation with Apoptotic Death in Drug-Resistant Temporal Lobe Epilepsy Patients Submitted to Surgery , 2018, Behavioral sciences.

[6]  Hong-bin Fan,et al.  Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination , 2018, Brain Research.

[7]  B. Silva,et al.  Brain expression of inflammatory mediators in Mesial Temporal Lobe Epilepsy patients , 2017, Journal of Neuroimmunology.

[8]  Y. Gao,et al.  Alteration of plasma cytokines in patients with active epilepsy , 2017, Acta neurologica Scandinavica.

[9]  F. Bartolomei,et al.  Anti–tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study , 2016, Epilepsia.

[10]  C. Limatola,et al.  GABAA currents are decreased by IL-1β in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis , 2015, Neurobiology of Disease.

[11]  G. Biagini,et al.  Ischemic–hypoxic mechanisms leading to hippocampal dysfunction as a consequence of status epilepticus , 2015, Epilepsy & Behavior.

[12]  A. Tardivel,et al.  NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes , 2015, PloS one.

[13]  Jin-Tai Yu,et al.  Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus , 2014, Journal of Neuroinflammation.

[14]  I. Aroch,et al.  Tumor Necrosis Factor‐α and Interleukin‐6 Concentrations in Cerebrospinal Fluid of Dogs After Seizures , 2014, Journal of veterinary internal medicine.

[15]  G. Biagini,et al.  Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic? , 2014, Current medicinal chemistry.

[16]  P. Rossini,et al.  Inflammation and iron metabolism in adult patients with epilepsy: Does a link exist? , 2013, Epilepsy Research.

[17]  D. Ingram,et al.  Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. , 2013, Cell metabolism.

[18]  R. Dingledine,et al.  The role of inflammation in epileptogenesis , 2013, Neuropharmacology.

[19]  Tuan Leng Tay,et al.  Love and death: microglia, NLRP3 and the Alzheimer's brain , 2013, Cell Research.

[20]  R. Dingledine,et al.  Ablation of Cyclooxygenase-2 in Forebrain Neurons is Neuroprotective and Dampens Brain Inflammation after Status Epilepticus , 2011, The Journal of Neuroscience.

[21]  M. McDermott,et al.  Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap) , 2008, Biologics : targets & therapy.

[22]  Giuseppe Biagini,et al.  The pilocarpine model of temporal lobe epilepsy , 2008, Journal of Neuroscience Methods.

[23]  Eleonora Aronica,et al.  Innate and adaptive immunity during epileptogenesis and spontaneous seizures: Evidence from experimental models and human temporal lobe epilepsy , 2008, Neurobiology of Disease.

[24]  R. Sankar,et al.  Inflammation Exacerbates Seizure‐induced Injury in the Immature Brain , 2007, Epilepsia.

[25]  G. Juhász,et al.  Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats , 2006, Neuroscience.

[26]  D. Fujikawa,et al.  Prolonged seizures and cellular injury: Understanding the connection , 2005, Epilepsy & Behavior.

[27]  T. Baram,et al.  Interleukin‐1β contributes to the generation of experimental febrile seizures , 2005, Annals of neurology.

[28]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.

[29]  D. Tousoulis,et al.  The Role of Inflammation , 2018 .

[30]  A. Andreazza,et al.  Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: A potential mediator between mitochondria and immune-activation. , 2016, Journal of psychiatric research.

[31]  M. Joghataei,et al.  Activation and Regulation of NLRP3 Inflammasome by Intrathecal Application of SDF-1a in a Spinal Cord Injury Model , 2015, Molecular Neurobiology.

[32]  H. Anders,et al.  Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.